OrbusNeich has obtained clearance from the FDA to market its Sapphire II PRO and Sapphire NC Plus percutaneous transluminal coronary angioplasty balloon dilatation catheters. The Sapphire NC Plus is intended for post-delivery expansion of balloon expandable coronary stents and in-stent restenosis dilatation, while the Sapphire II Pro enables entry through tight lesions because it comes with an ultra-low profile and a tapered tip.
FDA clears OrbusNeich's PTCA balloon dilatation catheters
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.